NEW YORK, September 14, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced the expansion of the National Health and Wellness Survey (NHWS) database in Brazil. NHWS is the largest international self-reported patient database in the healthcare industry.
“Brazil has the largest economy and population in Latin America, making it an attractive growth opportunity for pharmaceutical companies,” says Dave Pomerantz, Senior Vice President of Business Development with Kantar Health. “However, this is not a market to enter into without deep knowledge of the market and its patients. NHWS’s data helps global pharma companies gain an understanding of the Brazilian patient as well as the Brazilian healthcare market, which is different from the typical U.S. or EU market.”
The survey was completed by 12,000 Brazilian consumers. Topics covered include health status, attitudes, behaviors and outcomes among adults 18 or older. The survey also captures unique information specific to Brazil’s healthcare market, including:
- Use of national health insurance (Sistema Unico de Saude)
- Whether patients have paid out of pocket for a brand-name medication
- Where patients received their initial written prescription
- Socioeconomic data
The NHWS database provides broad coverage of healthcare, with results that are projected to the population to deliver prevalence information in more than 165 conditions. NHWS includes information for patients who are diagnosed, undiagnosed yet symptomatic, untreated and for patients treated with prescription and/or over-the-counter medications.
Kantar Health conducts NHWS annually in the US, Europe, Asia and Latin America. The database provides disease-specific measures that help healthcare clients:
- Size market opportunities
- Measure direct and indirect costs
- Gain insight into disease-specific segments
- Develop marketing and publication strategies directed at specific consumer or patient segments
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.